Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Motley Fool Transcribing - Rigel Pharma (RIGL) Earnings Call Transcript
Rigel Pharma (RIGL) Earnings Call Transcript
The Motley Fool

Tuesday, March 3, 2026 at 4:30 p.m. ET Chief Executive Officer — Raul R. Rodriguez Chief Commercial Officer — David A. Santos Chief Medical Officer — Lisa Rojkjaer Chief Financial Officer — Dean L. Schorno Need a quote…

seekingalpha.com - ONeil Trader - Ascendis Pharma: Yuviwel Approved Despite Legal Challenges (NASDAQ:ASND)
Ascendis Pharma: Yuviwel Approved Despite Legal Challenges (NASDAQ:ASND)
Seeking Alpha

Yuviwel is expected to add only modestly to 2024 revenues, with $30–40 million in 2026 net sales seen as a reasonable target given limited U.S. market penetration. The Yuviwel plus Skytrofa combination, showing much higher efficacy than…

yahoo.com - Maham Fatima - Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule
Yahoo!

Royalty Pharma (NASDAQ: RPRX) is one of the dirt cheap stocks to buy now. On February 11, Royalty Pharma reported a year of robust financial performance in 2025, marked by a 16% increase in total portfolio receipts and an 18% jump in Q4 alone. The…

yahoo.com - Maham Fatima - BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success
BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success
Yahoo!

BridgeBio Pharma Inc. (NASDAQ: BBIO) is one of the stocks with explosive growth potential. On February 24, BridgeBio Pharma reported a transformative full-year 2025, marked by a surge in total revenue to $502.1 million. This was driven largely by…

thehindu.com - N.Ravikumar - Natco Pharma launches generic of cancer drug in U.S.
Natco Pharma launches generic of cancer drug in U.S.
The Hindu

Natco Pharma along with its partner Breckenridge Pharmaceutical Inc has launched Pomalidomide Capsules, a generic version of Celgene's Pomalyst in the U.S. market. A thalidomide analogue, the product is indicated for the treatment of multiple…

thehindubusinessline.com - Natco Pharma launches Pomalidomide capsules in US
Natco Pharma launches Pomalidomide capsules in US
BusinessLine

Natco Pharma has announced the launch of Pomalidomide Capsules, a generic version of Pomalyst, in the US market. This product, developed in partnership with Breckenridge Pharmaceutical, Inc., is indicated for the treatment of adult patients with…

thehindubusinessline.com - Over 30 stocks including Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla, Juniper Hotels will hog limelight
Over 30 stocks including Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla, Juniper Hotels will hog limelight
BusinessLine

Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company's Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5…

marketbeat.com - TD Asset Management Inc Acquires 91,136 Shares of Royalty Pharma PLC $RPRX
TD Asset Management Inc Acquires 91,136 Shares of Royalty Pharma PLC $RPRX
MarketBeat

TD Asset Management Inc raised its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 88.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 194,202 shares of the…

marketbeat.com - Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO
Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Rafferty Asset Management LLC decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 22.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The…

marketbeat.com - Quantbot Technologies LP Makes New $2.82 Million Investment in Royalty Pharma PLC $RPRX
Quantbot Technologies LP Makes New $2.82 Million Investment in Royalty Pharma PLC $RPRX
MarketBeat

Quantbot Technologies LP bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 79,961 shares of the…

seekingalpha.com - SA Transcripts - Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha

Agilent Technologies, Inc. (A) TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM EST Adam Elinoff - Senior VP, CFO & Principal Financial Officer Tejas Savant - Vice President of Investor Relations Daniel Brennan - TD Cowen…

thehill.com - Joseph Choi - FDA sends warning to 30 telehealth companies selling 'illegal' GLP-1s
FDA sends warning to 30 telehealth companies selling 'illegal' GLP-1s
The Hill

The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the sale of these unapproved…

seekingalpha.com - SA Transcripts - Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha

Revvity, Inc. (RVTY) TD Cowen 46th Annual Health Care Conference March 3, 2026 2:30 PM EST Prahlad Singh - CEO, President & Director Daniel Brennan - TD Cowen, Research Division All right. Terrific. Welcome, day 2 of the TD Cowen Global Healthcare…

seekingalpha.com - SA Transcripts - Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Seeking Alpha

Danaher Corporation (DHR) TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM EST Rainer Blair - President, CEO & Director Daniel Brennan - TD Cowen, Research Division Terrific. Well, welcome. Day 2 of the TD Cowen Global Healthcare…

fool.com - Motley Fool Transcribing - Quanterix (QTRX) Q4 2025 Earnings Call Transcript
Quanterix (QTRX) Q4 2025 Earnings Call Transcript
The Motley Fool

President and Chief Executive Officer — Everett Cunningham Chief Financial Officer — Vandana Sriram Head of Investor Relations — Joshua Young Need a quote from a Motley Fool analyst? Email [email protected] Total Revenue --…

Receive a Daily briefing on Pharma Industry News

Get Started